lynestrenol has been researched along with Cell Transformation, Neoplastic in 2 studies
Lynestrenol: A synthetic progestational hormone used often in mixtures with estrogens as an oral contraceptive (CONTRACEPTIVES, ORAL).
Cell Transformation, Neoplastic: Cell changes manifested by escape from control mechanisms, increased growth potential, alterations in the cell surface, karyotypic abnormalities, morphological and biochemical deviations from the norm, and other attributes conferring the ability to invade, metastasize, and kill.
Excerpt | Relevance | Reference |
---|---|---|
" High norgestrel dosages caused atrophies of the corpus endometrium significantly more often than low norgestrel dosages, desogestrel or lynestrenol at low dosage levels." | 1.27 | [Dependence of morphologic changes in portio, cervix and endometrium on dosage or potency of synthetic gestagens]. ( Dallenbach-Hellweg, G; Fenzel, J, 1985) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 2 (100.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Wybran, J | 1 |
Thiry, L | 1 |
Dallenbach-Hellweg, G | 1 |
Fenzel, J | 1 |
2 other studies available for lynestrenol and Cell Transformation, Neoplastic
Article | Year |
---|---|
Delay of tumor growth in hamsters treated with lynestrenol and effect of Staphylococcus aureus Cowan A.
Topics: Animals; Antigens, Neoplasm; Cell Transformation, Neoplastic; Cricetinae; Female; Immunity; Immunoth | 1978 |
[Dependence of morphologic changes in portio, cervix and endometrium on dosage or potency of synthetic gestagens].
Topics: Cell Transformation, Neoplastic; Cervix Uteri; Desogestrel; Dose-Response Relationship, Drug; Endome | 1985 |